Pfizer CEO says COVID-19 vaccine booster dose 'likely' necessary within 12 months

It will probably be necessary for fully vaccinated people to head in for a third COVID-19 vaccine shot within a year, according to the head of Pfizer.
Pfizer CEO Albert Bourla says people will "likely" need to get a COVID-19 vaccine booster dose within 12 months after they've been fully vaccinated, CNBC reported on Thursday. His comments were reportedly made on April 1 but just became public.
"It is extremely important to suppress the pool of people that can be susceptible to the virus," he reportedly told CNBC at an event.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Bourla also reportedly said it's possible that getting vaccinated against COVID-19 annually will be necessary.
Previously, Pfizer said that an analysis of a phase 3 study found that its COVID-19 vaccine remained highly effective at least six months after the second dose. Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Disease, explained that with this data, "we know for sure" the vaccine is effective for six months, though it's "highly likely that it will be effective for considerably longer period of time." But Fauci added "we very well may need to get booster shots to keep up the level of protection." Moderna has also said its vaccine remains highly effective for at at least six months.
In February, Pfizer said that it was studying a booster dose of its vaccine, with Bourla at the time saying "we believe that the third dose will raise the antibody response 10-to-20 fold."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
The Nare Hotel: a charming hideaway on the Cornish coast
The Week Recommends Upgrade your classic seaside holiday at this five-star country house hotel
By Theo Tait Published
-
Today's political cartoons - March 6, 2025
Cartoons Thursday's cartoons - weird science, Hoover's heels, and more
By The Week US Published
-
Gilbert & George and the Communists: an 'illuminating' look at the 'peculiar' world of the art duo
The Week Recommends The collaborative art pair's journey to Moscow in 1990 is chronicled in this 'excellent' book
By The Week UK Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published